Leitzmann Michael F, Tsai Chung-Jyi, Stampfer Meir J, Willett Walter C, Giovannucci Edward
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, EPS-MSC 7232, 6120 Executive Boulevard, Bethesda, MD 20892, USA.
Arch Intern Med. 2005 Mar 14;165(5):567-73. doi: 10.1001/archinte.165.5.567.
Previous studies have suggested that thiazide diuretic use increases the risk of cholecystitis.
We prospectively examined the association between thiazide use and cholecystectomy, a surrogate for symptomatic cholelithiasis, in a cohort of 81 351 US women who were aged 30 to 55 years in 1980 and followed up to 2000. Regular use of thiazide diuretics was assessed at baseline by asking the participants to report whether they currently took "any of the following medications in most weeks" and listing "thiazide diuretics (eg, Diuril and Hydrodiuril)" among other drugs. Respondents were also requested to report the duration of thiazide diuretic use. Assessment of thiazide diuretic use was updated in 1982, 1988, 1994, 1996, and 1998. Cox regression was used to adjust simultaneously for other potential risk factors for cholecystectomy.
During follow-up, 8607 women reported undergoing a cholecystectomy. A modest positive relation between the use of thiazide diuretics and cholecystectomy was observed. Compared with never users of thiazide diuretics, the multivariate relative risk of cholecystectomy for past users was 1.16 (95% confidence interval,1.08-1.24) and the multivariate relative risk for current users was 1.39 (95% confidence interval, 1.29-1.50).
These findings are compatible with the hypothesis that the use of thiazide diuretics increases the risk of symptomatic cholecystitis. However, we cannot rule out the possibility that our results are in part explained by unconsidered factors related to the indication for antihypertensive therapy or by differences in medical surveillance between users and nonusers of thiazide diuretics.
既往研究提示,使用噻嗪类利尿剂会增加胆囊炎风险。
我们前瞻性地研究了噻嗪类药物使用与胆囊切除术(有症状胆石症的替代指标)之间的关联,研究对象为1980年年龄在30至55岁之间的81351名美国女性队列,随访至2000年。通过询问参与者是否“在大多数周内服用以下任何药物”并在其他药物中列出“噻嗪类利尿剂(如双氢克尿噻和氢氯噻嗪)”,在基线时评估噻嗪类利尿剂的常规使用情况。还要求受访者报告噻嗪类利尿剂的使用时长。1982年、1988年、1994年、1996年和1998年对噻嗪类利尿剂使用情况的评估进行了更新。采用Cox回归同时调整胆囊切除术的其他潜在风险因素。
随访期间,8607名女性报告接受了胆囊切除术。观察到噻嗪类利尿剂的使用与胆囊切除术之间存在适度的正相关关系。与从未使用过噻嗪类利尿剂的女性相比,既往使用者胆囊切除术的多因素相对风险为1.16(95%置信区间为1.08 - 1.24),当前使用者的多因素相对风险为1.39(95%置信区间为1.29 - 1.50)。
这些发现与噻嗪类利尿剂使用会增加有症状胆囊炎风险的假设相符。然而,我们不能排除以下可能性:我们的结果部分是由与抗高血压治疗指征相关的未考虑因素,或由噻嗪类利尿剂使用者与非使用者之间医疗监测差异所解释。